Navigation Links
Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market
Date:11/26/2009

ties as well as the established, trusted brand name offered by Cipla Ltd.

"Cipla Medpro creates and maintains strong brands by ensuring a robust pipeline of novel, high potential products, and by providing ongoing promotions and market support," adds Gerber. "These efforts support Cipla Medpro in growing its market share in the South African market."

The company enjoys leadership in customer value by offering competitive pricing of high quality products. It has ensured that its production plant meets international Pharmaceutical Inspection Convention Standards and the quality of its products is benchmarked against international standards.

Efficient distribution and ongoing marketing support has ensured that the Cipla Medpro brand is associated with efficiency and reliability. Furthermore, Cipla Medpro creates customer value by addressing the key challenges within the South African market.

"An example of this is its diversification into niche markets, such as the planned launch of its oncology division in 2010, which will address this market segment's need for affordable medicines," explains Gerber. "By supplying pharmaceuticals of the highest quality at affordable prices and addressing the growing needs of South African healthcare, Cipla Medpro has gained a competitive advantage."

Jerome Smith, Cipla Medpro South Africa Ltd CEO said he was extremely proud of Frost & Sullivan's acknowledgment of the company's efforts.

"Our comprehensive portfolio of scientifically advanced medicines, strong pipeline, swift registrations and numerous first to market launches including, recently, the first Biosimilar human insulin, are testimony of our commitment to one guiding ethos, that access to world class, yet affordable medicines is a right, not a luxury.

"The local pharmaceutical market is a competitive, regulated one however the growth potential is immense. In 2008, generics accounted for j
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Frost & Sullivan Recognizes Fovia for its HDVR(R) Platform - A Disruptive Technology Breakthrough
2. Central and Eastern European Healthcare Markets Hold Strong Potential for Growth Despite the Economic Slowdown, Says Frost & Sullivan
3. Lifesciences IT Spending to Experience Mature Growth Rates Despite Economic Slowdown, Declares Frost & Sullivan
4. Widening Application Range to Boost MRI Markets in Eastern Europe, Says Frost & Sullivan
5. Frost & Sullivan Identifies Focus on Quality Management and Adoption of a Full-service Model as Keys to the Growth of the European CRO Market
6. Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year
7. Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Technology Leadership Award
8. Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis
9. Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective
10. Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis
11. Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)...  Rigrodsky & Long, P.A.: , Do you, or ... AERI )? , Did you purchase your shares between August ... lose money in your investment in Aerie Pharmaceuticals, Inc.? , ... Rigrodsky & Long, P.A. , including former Special Assistant United ... has been filed in the United States District Court for the ...
(Date:5/6/2015)... , May 05, 2015 Research and ... the addition of the "Chromatography (Instruments and ... report to their offering. Chromatography is ... identifying the component of a complex mixture by ... the decades the scientists have considered chromatography as ...
(Date:5/6/2015)... YORK , May 6, 2015   CEFALY ... electrical nerve stimulation device specifically authorized for use prior ... announce significant breakthroughs in migraine treatment at the EUROHEADPAIN ... in Valencia, Spain , from May ... at a meeting of EUROHEADPAIN, a major European research ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 3Global Chromatography (Instruments and Reagents) Market 2015 - Forecasts to 2019 2CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2
... Inc., the largest,privately held spinal implant manufacturer in ... Spacers have been implanted under an,Investigational Device Exemption ... II and Dr. Rhett Murray., The FLEXUS(TM) ... two,spinous processes with minimal disruption to the surrounding ...
... (BiTE) showing clinical benefit in cancer,patients; Blinatumomab enables patients own T ... ... cancer cells, BETHESDA, Md., Aug. 14 Micromet, Inc.,(Nasdaq: ... treatment of cancer, inflammation and autoimmune,diseases, today announced publication of a ...
Cached Medicine Technology:First FLEXUS(TM) Interspinous Spacer Surgeries for IDE Clinical Trial 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6
(Date:5/6/2015)... Illinois (PRWEB) May 06, 2015 RPS Revolution ... take on the tried and true Rock Paper Scissors game ... With fun characters that encourage storytelling and easy to learn ... new twist on an old favorite. RPS Revolution ... it into whimsical characters that are grouped in set of ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Imprivata ... announced that CTO David Ting will lead a discussion ... associated data security and user authentication challenges, during ... The session will focus on the benefits of creating ... which care providers and patients can share information. It ...
(Date:5/6/2015)... 06, 2015 Qushanna Doby (20) was arrested ... drug treatment center in Florida while under the influence of ... New surveillance tapes released by CBS4’s Peter D’Oench records Doby ... Doby’s child is around one year old. The drug treatment ... outside was not named. The residents polled by CBS Miami ...
(Date:5/6/2015)... The Canton Group is joining Lardarius Webb ... annual charity softball game. The event takes place on Friday, ... Past years guests include Joe Flacco, John Harbaugh, Ed Reed ... sale if you are interested in attending. , The ... as SOAR Baltimore and The CollegeBound Foundation ...
(Date:5/6/2015)... May 06, 2015 TMG Health, the ... the Medicare Advantage, Medicare Part D and Managed Medicaid ... and Resilience Team category at the BCI North America ... to recognize the outstanding contribution of business continuity professionals ... America Region, including the USA and Canada. The North ...
Breaking Medicine News(10 mins):Health News:RPS Revolution Launches Kickstarter Campaign 2Health News:RPS Revolution Launches Kickstarter Campaign 3Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 3Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3
... , CAMBRIDGE, Mass., Sept. 9 ... enterprise content compliance software solutions for ... Software-as-a-Service (SaaS) solution for managing clinical trial disclosure requirements. The ... a robust offering that automates compliance with global regulatory mandates ...
... , NASHVILLE, Tenn., Sept. 9 ... provider of revenue and payment cycle management solutions, today ... Healthcare Network Accreditation Program (HNAP) from the Electronic Healthcare ... in health data processing and transactions and indicates compliance ...
... STOCKHOLM, September 9 Karolinska Development ... that will commercialize its,dermatology and wound healing opportunities as ... all of its,holdings from its five dermatology and wound ... company. , "This is a ...
... New Hearing ... ... website www.AdviceOnHearingAids.com is proving to be a valuable and informative resource for consumers ... aids, and so many different brands, styles, types of technology, and opinions about which one ...
... , TITUSVILLE, N.J., Sept. 9 Attention ... percent of children(1) and 4 percent of adults in the U.S.(2) ... 20 percent of U.S. school-aged children meet the Diagnostic and Statistical ... receiving an ADHD diagnosis.(3) Meanwhile, it is estimated that just 15 ...
... , , , HERMOSA ... empower parents across the globe to participate in the fight against AIDS ... ... go outside, go discover, go experience. Through the new partnership with ... to not only improve their own lives, but also the lives of ...
Cached Medicine News:Health News:Virtify Delivers SaaS Clinical Trial Disclosure Solution for Mid-Market Life Sciences Companies 2Health News:Virtify Delivers SaaS Clinical Trial Disclosure Solution for Mid-Market Life Sciences Companies 3Health News:Virtify Delivers SaaS Clinical Trial Disclosure Solution for Mid-Market Life Sciences Companies 4Health News:Emdeon Receives EHNAC Healthcare Network Re-accreditation 2Health News:Emdeon Receives EHNAC Healthcare Network Re-accreditation 3Health News:Karolinska Development Introduces New Concept for Development of its Dermatology and Wound Healing Portfolio 2Health News:Help for Hearing Loss - Now Available Online 2Health News:Help for Hearing Loss - Now Available Online 3Health News:CONCERTA(R) (methylphenidate HCI) LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 2Health News:CONCERTA(R) (methylphenidate HCI) LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 3Health News:CONCERTA(R) (methylphenidate HCI) LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 4Health News:CONCERTA(R) (methylphenidate HCI) LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 5Health News:'Go and Good Things Happen' with (BUGABOO)(RED) 2Health News:'Go and Good Things Happen' with (BUGABOO)(RED) 3Health News:'Go and Good Things Happen' with (BUGABOO)(RED) 4
... to the National Academy of ... use of cardiac markers in ... is definitive of acute myocardial ... assay was designed for rapid ...
A fluorogenic enzyme-linked immunoassay (ELISA) for the quantitative measurement of myoglobin in human serum or plasma aiding in the diagnosis of acute myocardial infarction (AMI). Features : Dry che...
Clinical marker immunoassay kit for detection of Myoglobin....
AxSYM Myoglobin is a Microparticle Enzyme Immunoassay (MEIA) for the quantitative determination of myoglobin in human serum or plasma on the AxSYM System....
Medicine Products: